Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05694650
Collaborator
(none)
20
1
35.6
0.6

Study Details

Study Description

Brief Summary

The objective of this qualitative research study is to assess the knowledge, attitudes and beliefs of cancer care providers, patients with cancer and caregivers regarding hospital care at home. We aim to conduct qualitative interviews to inform implementation of future on oncology hospital care at home programs

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Focus Group
  • Behavioral: Interview

Detailed Description

Interviews and focus groups will be conducted in English only using an interview guide (attached). The interview guide was based on the Consolidated Framework for Implementation Research (CFIR)8 to provide a broad understanding of the potential barriers and enablers of implementing a hospital care at home program. In summary, interviews will begin with an overview of the qualitative research study followed by verification of a completed demographic questionnaire

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers
Actual Study Start Date :
Oct 12, 2022
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Sep 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Focus

Participants will be asked about your previous experiences providing cancer care at MD Anderson and your thoughts on providing hospital care at home

Behavioral: Focus Group
Participants can meet with an interviewer alone. The focus group should take about 1 hour and will be held in person at MD Anderson, by telephone, or online using a video conferencing app called Zoom

Behavioral: Interview
Participants can meet with an interviewer alone. The interview should take about 1 hour and will be held in person at MD Anderson, by telephone, or online using a video conferencing app called Zoom

Interview

Participants will be asked about your previous experiences providing cancer care at MD Anderson and your thoughts on providing hospital care at home

Behavioral: Focus Group
Participants can meet with an interviewer alone. The focus group should take about 1 hour and will be held in person at MD Anderson, by telephone, or online using a video conferencing app called Zoom

Behavioral: Interview
Participants can meet with an interviewer alone. The interview should take about 1 hour and will be held in person at MD Anderson, by telephone, or online using a video conferencing app called Zoom

Outcome Measures

Primary Outcome Measures

  1. Quality of Life Questionnaires [through study completion an average of 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Cancer Care Providers
  • Cancer care providers of any specialty, including but not limited to oncologists, surgeons, hospitalists, emergency medicine physicians, nurses (including nurse practitioners), physician assistants, and any other member of the cancer care team (eg social workers or physical therapists)

  • Employed by the University of Texas MD Anderson Cancer Center

  1. Patients
  • Adults ages 18 and over

  • Currently undergoing or completed cancer treatment within the last 5 years at MD Anderson

  • Able to speak and read in English

  1. Caregivers
  • Adults ages 18 and over

  • Self-identifies as a caregiver of an individual over 18 who is currently undergoing cancer treatment or completed cancer treatment within the last 5 years at MD Anderson

  • Able to speak and read in English

Exclusion:

None

Contacts and Locations

Locations

Site City State Country Postal Code
1 M D Anderson Cancer Center Houston Texas United States 77030

Sponsors and Collaborators

  • M.D. Anderson Cancer Center

Investigators

  • Principal Investigator: Tacara Soones, MD, MPH, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT05694650
Other Study ID Numbers:
  • 2022-0654
  • NCI-2022-09841
First Posted:
Jan 23, 2023
Last Update Posted:
Jan 23, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 23, 2023